Pmu59 - Are There Any Implicit Guidelines for Including Adverse Events in Cost-Effectiveness Models Intended for French Health Authorities? An Analysis of Efficiency Opinions

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.1895
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Prm112 - Incorporation of Anti-Cancer Drugs Adverse Events in Health Economic Opinions of the French National Authority for Health (Has)

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Prm34 - French Efficiency Opinions of the Economic and Public Health Committee (Ceesp): Is There an Impact on the Market Access for Innovative Drugs?

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Religions: Are There Any?

Journal of the American Academy of Religion
Religious Studies
2010English

Adverse Events in Patients Taking Cephalosporins Versus Placebo for Any Indication

Cochrane Database of Systematic Reviews
2020English

Adverse Events in People Taking Macrolide Antibiotics Versus Placebo for Any Indication

Cochrane Database of Systematic Reviews
2019English

Are There Any Lazykids Around?

Journal of the Japanese Association for Petroleum Technology
2012English

Bayesian Models for Cost-Effectiveness Analysis in the Presence of Structural Zero Costs

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Are There Any Shock-Heated Galaxies

Astrophysical Journal
AstrophysicsAstronomyPlanetary ScienceSpace
1983English

Current Status of Health Foods Including Their Interactions With Drugs and Adverse Events

Yakugaku Zasshi
PharmacologyPharmaceutical Science
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy